Article
[Phenotype of peripheral blood lymphocytes in patients with lung cancer].
Voprosy onkologii - 1 Jan 2001
Oleĭnik E K, Oleĭnik V M, Bakhlaev I E, Ageenko A I
Abstract excerpt
The expression of surface markers of blood lymphocytes was studied in 32 lung cancer patients. Tumor process involved enhanced expression of the activation markers CD25, CD71 and HLA-DR as well as differentiation antigens CD4, CD8, CD22 and CD16. The expression of the markers was higher than in control, irrespective of stage, localization and histological pattern of tumor. It is suggested that increased...
Topics
- B-Lymphocytes
- Case-Control Studies
- Humans
- Immunophenotyping
- Lung Neoplasms
- Phenotype
- T-Lymphocytes
